{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:51:00Z","timestamp":1783486260915,"version":"3.55.0"},"reference-count":40,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":2358,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: The incidence and prevalence of hypothyroidism are increasing and the threshold for the treatment of hypothyroid as well as individuals without evident thyroid disease with thyroid hormone is declining. Objective: To investigate endocrinologists\u2019 use of thyroid hormones in hypothyroid and euthyroid patients in Italy, a country where different formulations of levothyroxine (LT4; tablet, liquid solution and soft-gel capsule) are available on the market. Methods: Members of the Associazione Medici Endocrinologi (Italian Association of Clinical Endocrinologists) were invited to participate in a web-based survey investigating the topic. Results: A total of 797 of 2,028 (39.3%) members completed all the sections of the survey; 98.7% declared that the treatment of choice for hypothyroidism is LT4. A significant minority (37.3%) indicated that LT4 may be considered in infertile euthyroid women seeking pregnancy and harbouring positive thyroperoxidase antibodies (TPOAb) and in goitre increasing in size (18.1%). LT4 + LT3 was considered by 43.2% for LT4-replaced patients and normal TSH, if they reported persistent symptoms. High percentages of respondents chose LT4 in a liquid solution or soft-gel capsules when taken together with other drugs interfering with LT4 absorption (81.8%), in patients with a history of celiac disease, malabsorption, lactose intolerance, intolerance to common excipients (96.6%), or unexplained poor biochemical control of hypothyroidism (74.4%), or in patients not able to adhere to ingesting LT4 fasted and\/or separated from food\/drink (98.9%). In total, 43.6% of responders would use LT4 in a liquid solution or soft-gel capsules for hypothyroid patients with biochemical euthyroidism on LT4, who had persistent symptoms. Conclusions: The preferred treatment for hypothyroidism is LT4; LT3 + LT4 combination treatment is mainly considered in patients with persistent symptoms. A significant minority would offer LT4 to euthyroid women with positive TPOAb and infertility and to euthyroid patients with progressive simple goitre. Alternative LT4 formulations like liquid solution or soft-gel capsules are largely reserved for specific conditions (interfering drugs, actual or suspected malabsorption, inability to take LT4 in the fasting state, unexplained poor biochemical control of hypothyroidism).<\/jats:p>","DOI":"10.1159\/000502057","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T17:00:35Z","timestamp":1567616435000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":46,"title":["Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients; the 2019 Italian Survey"],"prefix":"10.1530","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-4530","authenticated-orcid":false,"given":"Roberto","family":"Negro","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre\u00a0V.","family":"Nagy","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Papini","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Perros","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-7619","authenticated-orcid":false,"given":"Laszlo","family":"Heged\u00fcs","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"issue":"1","key":"2026070713085606500_ref1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/2168-6106","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/17425247.2016.1227782","article-title":"Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update","volume":"14","author":"Fallahi","year":"2017","journal-title":"Expert Opin Drug Deliv","ISSN":"https:\/\/id.crossref.org\/issn\/1742-5247","issn-type":"print"},{"issue":"2","key":"2026070713085606500_ref3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1210\/jc.2012-3125","article-title":"Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism","volume":"98","author":"Carswell","year":"2013","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"9","key":"2026070713085606500_ref4","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/13696998.2018.1484749","article-title":"The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US","volume":"21","author":"Hepp","year":"2018","journal-title":"J Med Econ","ISSN":"https:\/\/id.crossref.org\/issn\/1369-6998","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12020-017-1242-4","article-title":"Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015","volume":"58","author":"Ferrara","year":"2017","journal-title":"Endocrine","ISSN":"https:\/\/id.crossref.org\/issn\/1355-008X","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/13696998.2018.1443110","article-title":"The economic impact of switching from Synthroid for the treatment of hypothyroidism","volume":"21","author":"Khandelwal","year":"2018","journal-title":"J Med Econ","ISSN":"https:\/\/id.crossref.org\/issn\/1369-6998","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40268-016-0150-z","article-title":"Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study","volume":"17","author":"Ernst","year":"2017","journal-title":"Drugs R D","ISSN":"https:\/\/id.crossref.org\/issn\/1174-5886","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/PSY.0b013e3182738826","article-title":"The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects","volume":"75","author":"Faasse","year":"2013","journal-title":"Psychosom Med","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3174","issn-type":"print"},{"key":"2026070713085606500_ref9","doi-asserted-by":"publisher","first-page":"b5613","DOI":"10.1136\/bmj.b5613","article-title":"Medicine and the Media. Thyroxine: anatomy of a health scare","volume":"339","author":"Faasse","year":"2009","journal-title":"BMJ","ISSN":"https:\/\/id.crossref.org\/issn\/0959-8138","issn-type":"print"},{"issue":"2","key":"2026070713085606500_ref10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/thy.2018.0251","article-title":"Trends, Determinants, and Associations of Treated Hypothyroidism in the United Kingdom, 2005-2014","volume":"29","author":"Razvi","year":"2019","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"3","key":"2026070713085606500_ref11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000437262","article-title":"Treating Hypothyroidism with Thyroxine\/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?","volume":"4","author":"Michaelsson","year":"2015","journal-title":"Eur Thyroid J","ISSN":"https:\/\/id.crossref.org\/issn\/2235-0640","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/thy.2017.0681","article-title":"An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction","volume":"28","author":"Peterson","year":"2018","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref13","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/jc.2014-1046","article-title":"A 2013 survey of clinical practice patterns in the management of primary hypothyroidism","volume":"99","author":"Burch","year":"2014","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"11","key":"2026070713085606500_ref14","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1089\/thy.2018.0325","article-title":"Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics","volume":"28","author":"Jonklaas","year":"2018","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"2","key":"2026070713085606500_ref15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000339444","article-title":"2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism","volume":"1","author":"Wiersinga","year":"2012","journal-title":"Eur Thyroid J","ISSN":"https:\/\/id.crossref.org\/issn\/2235-0640","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1089\/thy.2017.0517","article-title":"Over- and Under-Treatment of Hypothyroidism Is Associated with Excess Mortality: A Register-Based Cohort Study","volume":"28","author":"Lillevang-Johansen","year":"2018","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-19-0006","article-title":"Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk","volume":"180","author":"Lillevang-Johansen","year":"2019","journal-title":"Eur J Endocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0804-4643","issn-type":"print"},{"issue":"3","key":"2026070713085606500_ref18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1210\/jc.2017-01986","article-title":"High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma","volume":"103","author":"Mazziotti","year":"2018","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/thy.2013.0555","article-title":"Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study","volume":"24","author":"Thvilum","year":"2014","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref20","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1210\/jc.2017-02668","article-title":"Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects","volume":"103","author":"Samuels","year":"2018","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cen.13345","article-title":"Free triiodothyronine\/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects","volume":"87","author":"Park","year":"2017","journal-title":"Clin Endocrinol (Oxf)","ISSN":"https:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref22","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1210\/jc.2016-1049","article-title":"Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth","volume":"101","author":"Plowden","year":"2016","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"14","key":"2026070713085606500_ref23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1056\/NEJMoa1812537","article-title":"Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception","volume":"380","author":"Dhillon-Smith","year":"2019","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"10","key":"2026070713085606500_ref24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"issue":"5","key":"2026070713085606500_ref25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.4158\/EP161208.GL","article-title":"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES\u20142016 UPDATE","volume":"22","author":"Gharib","year":"2016","journal-title":"Endocr Pract","ISSN":"https:\/\/id.crossref.org\/issn\/1530-891X","issn-type":"print"},{"issue":"11","key":"2026070713085606500_ref26","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1210\/jc.2003-030095","article-title":"Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid","volume":"88","author":"Brenta","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/er.2012-1030","article-title":"Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome","volume":"33","author":"Bonnema","year":"2012","journal-title":"Endocr Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0163-769X","issn-type":"print"},{"issue":"3","key":"2026070713085606500_ref28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1871530318666180125155348","article-title":"Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients","volume":"18","author":"Guglielmi","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets","ISSN":"https:\/\/id.crossref.org\/issn\/1871-5303","issn-type":"print"},{"issue":"2","key":"2026070713085606500_ref29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.2015.0422","article-title":"A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: results of the TICO Study","volume":"26","author":"Cappelli","year":"2016","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"12","key":"2026070713085606500_ref30","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1210\/jc.2014-2684","article-title":"Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors","volume":"99","author":"Vita","year":"2014","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"4","key":"2026070713085606500_ref31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/17425247.2017.1290604","article-title":"Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs","volume":"14","author":"Vita","year":"2017","journal-title":"Expert Opin Drug Deliv","ISSN":"https:\/\/id.crossref.org\/issn\/1742-5247","issn-type":"print"},{"issue":"6","key":"2026070713085606500_ref32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-014-0082-9","article-title":"Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube","volume":"37","author":"Pirola","year":"2014","journal-title":"J Endocrinol Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0391-4097","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11695-016-2247-4","article-title":"TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation","volume":"27","author":"Fallahi","year":"2017","journal-title":"Obes Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0960-8923","issn-type":"print"},{"issue":"12","key":"2026070713085606500_ref34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-0032-1329951","article-title":"Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms","volume":"62","author":"Yue","year":"2012","journal-title":"Arzneimittelforschung","ISSN":"https:\/\/id.crossref.org\/issn\/0004-4172","issn-type":"print"},{"key":"2026070713085606500_ref35","unstructured":"American Association of Clinical Endocrinologists\n          . the Endocrine Society, and the American Thyroid Association Joint Position Statement on the Use and Interchangeability of Thyroxine Products, 2004. www.thyroid.org\/ thyroxine-products-joint-position-statement"},{"key":"2026070713085606500_ref36","unstructured":"U.S. Food and Drug Administration\n          . FDA acts to ensure thyroid drugs don\u2019t lose potency before expiration date. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm161259.htm 104."},{"key":"2026070713085606500_ref37","unstructured":"U.S. Food and Drug Administration\n          . Questions and answers on levothyroxine sodium products. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm161266.htm"},{"issue":"12","key":"2026070713085606500_ref38","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"2","key":"2026070713085606500_ref39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2013-1891","article-title":"European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism","volume":"99","author":"L\u00e9ger","year":"2014","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"1","key":"2026070713085606500_ref40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid","ISSN":"https:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/502057","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/9\/1\/25\/35952\/etj502057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/9\/1\/25\/35952\/etj502057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:48:48Z","timestamp":1783446528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/9\/1\/25\/4908\/Use-of-Thyroid-Hormones-in-Hypothyroid-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000502057","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,4]]}}}